• Privacy
  • Terms
  • Contact
Sunday, June 22, 2025
Choose Your Area
The LA Monitor
  • Home
  • About
  • Submit News Tip
  • LA Monitor Exclusives & Reports
  • Local News
    • Los Angeles
    • San Fernando Valley
    • San Gabriel Valley
    • South Bay
    • Long Beach
    • Orange County
  • California
  • Crime
  • Business
  • More
    • Politics
    • Entertainment
    • Health
    • Sports
No Result
View All Result
  • Home
  • About
  • Submit News Tip
  • LA Monitor Exclusives & Reports
  • Local News
    • Los Angeles
    • San Fernando Valley
    • San Gabriel Valley
    • South Bay
    • Long Beach
    • Orange County
  • California
  • Crime
  • Business
  • More
    • Politics
    • Entertainment
    • Health
    • Sports
No Result
View All Result
The LA Monitor
No Result
View All Result
  • LA Monitor Exclusives & Reports
  • Local News
  • California
  • Crime
  • Business
  • Entertainment
  • Health
  • Politics
  • Sports
Home Health

Department of Public Health Says ‘Xylazine’ Likely Present in Los Angeles Drug Supply, Contributing to Overdoses

Xylazine is a sedative and muscle relaxant drug used by veterinarians to anesthetize animals

The LA Monitor by The LA Monitor
Mar 8, 2023 4:03 pm EST
in Health, LA Monitor Exclusives & Reports
0 0
A A
0
Share on FacebookShare on Twitter

LOS ANGELES, Ca. — The Los Angeles Department of Public Health is warning residents of the increased risk of overdose and death associated with “xylazine,” a sedative and muscle relaxant drug used by veterinarians to anesthetize animals. Xylazine has the nickname “zombie drug.”

Health officials say xylazine is increasingly present in illicit drugs in California. Recently, San Francisco reported four overdose deaths involving both xylazine and fentanyl in 2023.

Health officials Xylazine “comes in a clear liquid that is cooked down into a powder form and is mixed with illicit opioids such as heroin or fentanyl, or pressed into counterfeit pills (e.g., Norco, Percocet, Vicodin, etc.) or sedatives (Xanax) as a cheap additive to increase the effects of these drugs.”

Health officials say when mixed with opioids and other central nervous system depressants, xylazine intensifies the effects. This includes drowsiness leading to unresponsiveness and slowed or stopped breathing, which can lead to a fatal overdose.

Many purchasing illicit drugs don’t know that xylazine may be present in the drugs they are trying to obtain.

The Los Angeles Department of Public Health says there is no test to determine if illicit drugs contain xylazine.

Health officials say these are the signs of a xylazine overdose:

  • Excessive sedation and appearing unresponsive
  • Slowed breathing
  • Slowed heart rate
  • Low blood pressure
  • Cold, clammy skin

While you can’t easily detect Xylazine, you can still use Fentanyl Test Strips to identify drugs contaminated with fentanyl. They require dissolving a small amount of the drug supply in water, dipping the test strip into the liquid, and waiting 15 seconds for a result.

Fentanyl testing strips can be purchased online at:

  • Team Awareness Combating Overdose (TACO) Inc: http://www.tacoinc.org/teststrips
  • Dose Test: http://dosetest.com/product/fentanyl-test-strip
  • Dance Safe: http://dancesafe.org/shop

Services and Bed Availability Tool (SBAT) helps you find substance use treatment services and bed availability in Los Angeles using an online: www.RecoverLA.org. Services include outpatient and intensive outpatient treatment, residential treatment, withdrawal management, and Opioid Treatment Programs.

Substance Abuse Service Helpline: 844-804-7500

Stock feature photo, courtesy of: Kevin Bidwell

Have a news tip for The LA Monitor? Submit your news tip or article here.
Tags: Department of Public Healthhealthhealth alertLA DPHLos Angeles Department of Public HealthLos Angeles DPH
ShareTweetSharePinShareSendSend
The LA Monitor

The LA Monitor

The LA Monitor is your number one website for the latest news and updates about Los Angeles. follow us now to get the news that matters to you.

Related Articles

Health

Supreme Court widens court options for vaping companies pushing back against FDA rules

Jun 20, 2025 2:29 pm EDT
Health

‘We held our ground’: LA health clinic describes close encounter with immigration agents

Jun 15, 2025 5:40 pm EDT
Health

Should you let pets sleep next to you? (Does it even matter what the experts say?)

Jun 12, 2025 4:22 pm EDT
Health

Newsom’s push to block law could save California nursing homes over $1 billion

Jun 4, 2025 2:59 pm EDT
Health

RFK Jr. says healthy pregnant women don’t need COVID boosters. What the science says

Jun 4, 2025 2:02 pm EDT
Health

Dogs and cats can also suffer from allergies, but there are ways to help our furry friends

Jun 3, 2025 2:01 pm EDT
The LA Monitor

The LA Monitor is your number one website for the latest news and updates about Los Angeles. follow us now to get the news that matters to you.

Trending Topics

  • Business
  • California
  • Crime
  • Entertainment
  • Health
  • LA Monitor Exclusives & Reports
  • Local News
  • Long Beach
  • Los Angeles
  • Orange County
  • Politics
  • San Fernando Valley
  • San Gabriel Valley
  • South Bay
  • Sports
  • Uncategorized

Quick Links

  • About
  • Submit News Tip
  • Advertise
  • Customer Support
  • Cookie Policy
  • Privacy
  • Terms
  • Contact

© 2023 The LA Monitor - All Rights Reserved.

No Result
View All Result
  • Home
  • About
  • Submit News Tip
  • LA Monitor Exclusives & Reports
  • Local News
    • Los Angeles
    • San Fernando Valley
    • San Gabriel Valley
    • South Bay
    • Long Beach
    • Orange County
  • California
  • Crime
  • Business
  • More
    • Politics
    • Entertainment
    • Health
    • Sports

© 2023 The LA Monitor - All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.